Continue to Innovate Services, Therapies and Products

Mening C

Smallpox

Influenza

Current Products

• Licensed in Europe

• Filing in Latin America in 2002

• US clinicals to begin in 2002

• Production of 155 million dosesfor U.S. government

• Other countries assessing stockpile

• Approved by Netherlands

• US clinicals to begin in 2002

• 2003 limited launch

TBE

• Launched in Austria & in severalEU countries

• Clinicals in Germany underway

Examples of

Pipeline Products

Mening CYW

Group A Strep

Group B Strep

Urinary Tract Infection

Lyme Disease

Vaccines Portfolio

Previous slide

Next slide

Back to first slide

View graphic version